30.06.2025 Substandard Cancer Drugs in Africa Are A Serious Concern An alarming investigation has revealed the prevalence of substandard cancer drugs in Africa, putting patients at risk with ineffective treatments. This article is for Health Matters subscribers Subscribers read every article in full, receive the daily briefing and have access to the complete archive. SubscribeLog in Africa, cancer, Counterfeit Drugs, healthcare, Medicine Quality, Patient Safety, Pharmaceutical Regulation, Public Health, The Lancet, WHO